<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Lambalk, C.B.</title>
    <link>http://repub.eur.nl/res/aut/7559/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Evidence that the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in human serum may not be secreted by the pituitary gland (Article)</title>
      <link>http://repub.eur.nl/res/pub/8740/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Recent studies have revealed that TRH-like immunoreactivity (TRH-LI) in
          human serum is predominantly pGlu-Glu-ProNH2 (&lt; EEP-NH2), a peptide
          previously found in, among others tissues, the pituitary gland of various
          mammalian species. In the rat pituitary, &lt; EEP-NH2 is present in
          gonadotrophs and its pituitary content is regulated by gonadal steroids
          and gonadotrophin-releasing hormone (GnRH). Hence, we reasoned that &lt;
          EEP-NH2 in human serum may also arise, at least in part, from the
          pituitary, and that its secretion may correlate with that of
          gonadotrophins. Therefore, blood was simultaneously sampled from both
          inferior petrosal sinuses, which are major sites of the venous drainage of
          the pituitary gland, and a peripheral vein from seven patients with
          suspected adrenocorticotrophin-secreting pituitary tumours. In addition,
          in six postmenopausal and six cyclic women, peripheral vein blood was
          collected at 10-min intervals for 6 h, then a standard 100 micrograms GnRH
          test was performed. In the sera, TRH-LI was estimated by RIA with
          antiserum 4319, which binds most tripeptides that share the N- and
          C-terminal amino acids with TRH (pGlu-His-ProNH2). In addition, LH and FSH
          were measured in these sera by RIA. In the blood samples taken at 10-min
          intervals, an episodic variation in serum TRH-LI was noted and pulses of
          TRH-LI were detected at irregular intervals (from one to six pulses per 6
          h) in five postmenopausal and six cyclic women. In general, these pulses
          did not coincide with those of LH and FSH, suggesting that TRH-LI is not
          co-secreted with gonadotrophins. Moreover, unlike LH and FSH, serum TRH-LI
          did not increase during the menopause or after exogenous administration of
          GnRH. Whereas gonadotrophin concentrations were significantly greater in
          the inferior petrosal sinus than in peripheral serum, there were no
          differences in TRH-LI concentrations between these serum samples. In
          conclusion, serum TRH-LI in humans seems not to be regulated by gonadal
          steroids or GnRH. Moreover, serum derived directly from the pituitary
          contained no more TRH-LI than did peripheral serum, which suggests that
          the human pituitary gland does not secrete significant amounts of &lt;
          EEP-NH2, and therefore does not contribute significantly to serum TRH-LI
          concentrations. Further research is required to identify the site of
          origin of &lt; EEP-NH2 in human serum.</description>
    </item>
  </channel>
</rss>